Recent advances in mucosal immunization using virus-like particles

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 1596-1609

  Vacher, Gaëlle ^a   Kaeser, Matthias D ^b   Moser, Christian ^b   Gurny, Robert ^a   Borchard, Gerrit ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Pevion Biotech AG   (Switzerland)

Author keywords

mucosal immunization; vaccine; virosomes; virus like particles

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOLOGICAL ADJUVANT; INFLUENZA VIROSOME; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE; VIROSOME; VIRUS LIKE PARTICLE VACCINE;

CLINICAL STUDY; CPG ISLAND; DRUG DELIVERY SYSTEM; DRUG MARKETING; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; MOLECULAR MIMICRY; MUCOSAL IMMUNITY; MUCOSAL IMMUNIZATION; NONHUMAN; NOROVIRUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; REVIEW; VIRUS CAPSID; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; ANIMAL; IMMUNOLOGY; PROCEDURES; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNITY, MUCOSAL; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE; VIRAL STRUCTURAL PROTEINS; VIROSOMES;

EID: 84877256491     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300597g     Document Type: Review

References (155)

1. Arnon, R. Overview of vaccine strategies. In Vaccine design Innovative approaches and novel strategies; Rappuoli, R., Bagnoli, F., Eds.; Caister Academic Press: Norwolk, UK, 2011; pp 1-19.
2. Ulmer, J. B.; Valley, U.; Rappuoli, R. Vaccine manufacturing: challenges and solutions Nat. Biotechnol. 2006, 24 (11) 1377-83
3. Neutra, M. R.; Kozlowski, P. A. Mucosal vaccines: the promise and the challenge Nat. Rev. Immunol. 2006, 6 (2) 148-58
4. Giudice, E. L.; Campbell, J. D. Needle-free vaccine delivery Adv. Drug Delivery Rev. 2006, 58 (1) 68-89
5. Gluck, R.; Mischler, R.; Durrer, P.; Furer, E.; Lang, A. B.; Herzog, C.; Cryz, S. J., Jr. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant J. Infect. Dis. 2000, 181 (3) 1129-32
6. Holmgren, J.; Czerkinsky, C. Mucosal immunity and vaccines Nat. Med. 2005, 11 (4 Suppl) S45-S53
7. Ravindran, R.; B., P. Mucosal vaccines. In Vaccine Design Innovative Approaches and novel strategies, Rappuoli, R.; Bagnoli, F., Eds.; Caister Academic Press: Norfolk, UK, 2011; pp 171-209.
8. Mondel, M.; Schroeder, B. O.; Zimmermann, K.; Huber, H.; Nuding, S.; Beisner, J.; Fellermann, K.; Stange, E. F.; Wehkamp, J.; Probiotic, E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans Mucosal Immunol. 2009, 2 (2) 166-72
9. Lavelle, E. C.; Murphy, C.; O'Neill, L. A.; Creagh, E. M. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis Mucosal Immunol. 2010, 3 (1) 17-28
10. West, A. P.; Koblansky, A. A.; Ghosh, S. Recognition and signaling by toll-like receptors Annu. Rev. Cell Dev. Biol. 2006, 22, 409-37
11. Sajic, D.; Patrick, A. J.; Rosenthal, K. L. Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina Immunology 2005, 114 (2) 213-24
12. Coffin, S. E.; Clark, S. L.; Bos, N. A.; Brubaker, J. O.; Offit, P. A. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization J. Immunol. 1999, 163 (6) 3064-70
13. Macpherson, A. J.; McCoy, K. D.; Johansen, F. E.; Brandtzaeg, P. The immune geography of IgA induction and function Mucosal Immunol. 2008, 1 (1) 11-22
14. Pakkanen, S. H.; Kantele, J. M.; Moldoveanu, Z.; Hedges, S.; Hakkinen, M.; Mestecky, J.; Kantele, A. Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids Clin. Vaccine Immunol. 2010, 17 (3) 393-401
15. Mora, J. R.; Iwata, M.; Eksteen, B.; Song, S. Y.; Junt, T.; Senman, B.; Otipoby, K. L.; Yokota, A.; Takeuchi, H.; Ricciardi-Castagnoli, P.; Rajewsky, K.; Adams, D. H.; von Andrian, U. H. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells Science 2006, 314 (5802) 1157-60
16. He, B.; Xu, W.; Santini, P. A.; Polydorides, A. D.; Chiu, A.; Estrella, J.; Shan, M.; Chadburn, A.; Villanacci, V.; Plebani, A.; Knowles, D. M.; Rescigno, M.; Cerutti, A. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL Immunity 2007, 26 (6) 812-26
17. Bessa, J.; Jegerlehner, A.; Hinton, H. J.; Pumpens, P.; Saudan, P.; Schneider, P.; Bachmann, M. F. Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses J. Immunol. 2009, 183 (6) 3788-99
18. Lamm, M. E. Interaction of antigens and antibodies at mucosal surfaces Annu. Rev. Microbiol. 1997, 51, 311-40
19. Wijburg, O. L.; Uren, T. K.; Simpfendorfer, K.; Johansen, F. E.; Brandtzaeg, P.; Strugnell, R. A. Innate secretory antibodies protect against natural Salmonella typhimurium infection J. Exp. Med. 2006, 203 (1) 21-6
20. Holmgren, J.; Czerkinsky, C.; Eriksson, K.; Mharandi, A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges Vaccine 2003, 21 (Suppl 2) S89-95
21. Ball, J. M.; Hardy, M. E.; Atmar, R. L.; Conner, M. E.; Estes, M. K. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice J. Virol. 1998, 72 (2) 1345-53
22. Santi, L.; Batchelor, L.; Huang, Z.; Hjelm, B.; Kilbourne, J.; Arntzen, C. J.; Chen, Q.; Mason, H. S. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles Vaccine 2008, 26 (15) 1846-54
23. Balmelli, C.; Roden, R.; Potts, A.; Schiller, J.; De Grandi, P.; Nardelli-Haefliger, D. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions J. Virol. 1998, 72 (10) 8220-9
24. Fraillery, D.; Zosso, N.; Nardelli-Haefliger, D. Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles Vaccine 2009, 27 (17) 2326-34
25. Shuttleworth, G.; Eckery, D. C.; Awram, P. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice Arch. Virol. 2005, 150 (2) 341-9
26. Kang, S. M.; Yao, Q.; Guo, L.; Compans, R. W. Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B J. Virol. 2003, 77 (18) 9823-30
27. Hunter, Z.; Smyth, H. D.; Durfee, P.; Chackerian, B. Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine Vaccine 2009, 28 (2) 403-14
28. Agnello, D.; Herve, C. A.; Lavaux, A.; Darniot, M.; Guillon, P.; Charpilienne, A.; Pothier, P. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice J. Virol. 2006, 80 (8) 3823-32
29. Fromantin, C.; Jamot, B.; Cohen, J.; Piroth, L.; Pothier, P.; Kohli, E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response J. Virol. 2001, 75 (22) 11010-6
30. O'Neal, C. M.; Clements, J. D.; Estes, M. K.; Conner, M. E. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge J. Virol. 1998, 72 (4) 3390-3
31. Park, J. S.; Oh, Y. K.; Kang, M. J.; Kim, C. K. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems J. Med. Virol. 2003, 70 (4) 633-41
32. Lehner, T.; Brookes, R.; Panagiotidi, C.; Tao, L.; Klavinskis, L. S.; Walker, J.; Walker, P.; Ward, R.; Hussain, L. Gearing, J. H.; et al. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (18) 8638-42
33. Klavinskis, L. S.; Bergmeier, L. A.; Gao, L.; Mitchell, E.; Ward, R. G.; Layton, G.; Brookes, R.; Meyers, N. J.; Lehner, T. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes J. Immunol. 1996, 157 (6) 2521-7
34. Yuan, L.; Geyer, A.; Hodgins, D. C.; Fan, Z.; Qian, Y.; Chang, K. O.; Crawford, S. E.; Parreno, V.; Ward, L. A.; Estes, M. K.; Conner, M. E.; Saif, L. J. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs J. Virol. 2000, 74 (19) 8843-53
35. Yuan, L.; Iosef, C.; Azevedo, M. S.; Kim, Y.; Qian, Y.; Geyer, A.; Nguyen, T. V.; Chang, K. O.; Saif, L. J. Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs J. Virol. 2001, 75 (19) 9229-38
36. Kang, S. M.; Compans, R. W. Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus J. Virol. 2003, 77 (6) 3615-23
37. Iosef, C.; Van Nguyen, T.; Jeong, K.; Bengtsson, K.; Morein, B.; Kim, Y.; Chang, K. O.; Azevedo, M. S.; Yuan, L.; Nielsen, P.; Saif, L. J. Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like- particles associated with immunostimulating complexes Vaccine 2002, 20 (13-14) 1741-53
38. Gonzalez, A. M.; Nguyen, T. V.; Azevedo, M. S.; Jeong, K.; Agarib, F.; Iosef, C.; Chang, K.; Lovgren-Bengtsson, K.; Morein, B.; Saif, L. J. Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM Clin. Exp. Immunol. 2004, 135 (3) 361-72
39. Martin, M.; Michalek, S. M.; Katz, J. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A Infect. Immun. 2003, 71 (5) 2498-507
40. El-Kamary, S. S.; Pasetti, M. F.; Mendelman, P. M.; Frey, S. E.; Bernstein, D. I.; Treanor, J. J.; Ferreira, J.; Chen, W. H.; Sublett, R.; Richardson, C.; Bargatze, R. F.; Sztein, M. B.; Tacket, C. O. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues J. Infect Dis. 2010, 202 (11) 1649-58
41. Gewirtz, A. T.; Navas, T. A.; Lyons, S.; Godowski, P. J.; Madara, J. L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression J. Immunol. 2001, 167 (4) 1882-5
42. Wang, B. Z.; Xu, R.; Quan, F. S.; Kang, S. M.; Wang, L.; Compans, R. W. Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection PLoS One 2010, 5 (11) e13972
43. Wang, B. Z.; Gill, H. S.; Kang, S. M.; Wang, L.; Wang, Y. C.; Vassilieva, E. V.; Compans, R. W. Enhanced influenza VLP vaccines containing M2e and a TLR ligand Clin. Vaccine Immunol. 2012, 1119-25
44. Vassilieva, E. V.; Wang, B. Z.; Vzorov, A. N.; Wang, L.; Wang, Y. C.; Bozja, J.; Xu, R.; Compans, R. W. Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant MBio 2011, 2 (1) e00328-10
45. Klinman, D. M. Adjuvant activity of CpG oligodeoxynucleotides Int. Rev. Immunol. 2006, 25 (3-4) 135-54
46. Lu, B.; Huang, Y.; Huang, L.; Li, B.; Zheng, Z.; Chen, Z.; Chen, J.; Hu, Q.; Wang, H. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice Immunology 2010, 130 (2) 254-61
47. Bessa, J.; Schmitz, N.; Hinton, H. J.; Schwarz, K.; Jegerlehner, A.; Bachmann, M. F. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design Eur. J. Immunol. 2008, 38 (1) 114-26
48. Gorden, K. B.; Gorski, K. S.; Gibson, S. J.; Kedl, R. M.; Kieper, W. C.; Qiu, X.; Tomai, M. A.; Alkan, S. S.; Vasilakos, J. P. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8 J. Immunol. 2005, 174 (3) 1259-68
49. Bachmann, M. F.; Jennings, G. T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns Nat. Rev. Immunol. 2010, 10 (11) 787-96
50. Adkins, I.; Holubova, J.; Kosova, M.; Sadilkova, L. Bacteria and their toxins tamed for immunotherapy Curr. Pharm. Biotechnol. 2012, 13 (8) 1446-73
51. Coffman, R. L.; Sher, A.; Seder, R. A. Vaccine adjuvants: putting innate immunity to work Immunity 2010, 33 (4) 492-503
52. Mutsch, M.; Zhou, W.; Rhodes, P.; Bopp, M.; Chen, R. T.; Linder, T.; Spyr, C.; Steffen, R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland N. Engl. J. Med. 2004, 350 (9) 896-903
53. Lewis, D. J.; Huo, Z.; Barnett, S.; Kromann, I.; Giemza, R.; Galiza, E.; Woodrow, M.; Thierry-Carstensen, B.; Andersen, P.; Novicki, D.; Del Giudice, G.; Rappuoli, R. Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin PloS One 2009, 4 (9) e6999
54. Brady, J. N.; Consigli, R. A. Chromatographic separation of the polyoma virus proteins and renaturation of the isolated VP1 major capsid protein J. Virol. 1978, 27 (2) 436-42
55. Kingsman, S. M.; Kingsman, A. J. Polyvalent recombinant antigens: a new vaccine strategy Vaccine 1988, 6 (4) 304-6
56. Grgacic, E. V.; Anderson, D. A. Virus-like particles: passport to immune recognition Methods 2006, 40 (1) 60-5
57. El-Attar, L.; Oliver, S. L.; Mackie, A.; Charpilienne, A.; Poncet, D.; Cohen, J.; Bridger, J. C. Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease Vaccine 2009, 27 (24) 3201-8
58. Quan, F. S.; Sailaja, G.; Skountzou, I.; Huang, C.; Vzorov, A.; Compans, R. W.; Kang, S. M. Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins Vaccine 2007, 25 (19) 3841-50
59. Sailaja, G.; Skountzou, I.; Quan, F. S.; Compans, R. W.; Kang, S. M. Human immunodeficiency virus-like particles activate multiple types of immune cells Virology 2007, 362 (2) 331-41
60. Buonaguro, F. M.; Tornesello, M. L.; Buonaguro, L. Virus-like particle vaccines and adjuvants: the HPV paradigm Expert Rev. Vaccines 2009, 8 (10) 1379-98
61. Yildiz, I.; Shukla, S.; Steinmetz, N. F. Applications of viral nanoparticles in medicine Curr. Opin. Biotechnol. 2011, 22 (6) 901-8
62. Moser, C.; Amacker, M.; Zurbriggen, R. Influenza virosomes as a vaccine adjuvant and carrier system Expert Rev. Vaccines 2011, 10 (4) 437-46
63. Almanza, H.; Cubillos, C.; Angulo, I.; Mateos, F.; Caston, J. R.; van der Poel, W. H.; Vinje, J.; Barcena, J.; Mena, I. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II J. Clin. Microbiol. 2008, 46 (12) 3971-9
64. Shin, Y. C.; Folk, W. R. Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor J. Virol. 2003, 77 (21) 11491-8
65. Hoss, A.; Moarefi, I.; Scheidtmann, K. H.; Cisek, L. J.; Corden, J. L.; Dornreiter, I.; Arthur, A. K.; Fanning, E. Altered phosphorylation pattern of simian virus 40 T antigen expressed in insect cells by using a baculovirus vector J. Virol. 1990, 64 (10) 4799-807
66. Roldao, A.; Mellado, M. C.; Castilho, L. R.; Carrondo, M. J.; Alves, P. M. Virus-like particles in vaccine development Expert Rev. Vaccines 2010, 9 (10) 1149-76
67. Vicente, T.; Roldao, A.; Peixoto, C.; Carrondo, M. J.; Alves, P. M. Large-scale production and purification of VLP-based vaccines J. Invertebr. Pathol. 2011, 107 (Suppl) S42-8
68. Noad, R.; Roy, P. Virus-like particles as immunogens Trends Microbiol. 2003, 11 (9) 438-44
69. Ellis, R. W. The new generation of recombinant viral subunit vaccines Curr. Opin. Biotechnol. 1996, 7 (6) 646-52
70. Hines, J. F.; Ghim, S.; Schlegel, R.; Jenson, A. B. Prospects for a vaccine against human papillomavirus Obstet. Gynecol. 1995, 86 (5) 860-6
71. Doan, L. X.; Li, M.; Chen, C.; Yao, Q. Virus-like particles as HIV-1 vaccines Rev. Med. Virol. 2005, 15 (2) 75-88
72. Bertolotti-Ciarlet, A.; White, L. J.; Chen, R.; Prasad, B. V.; Estes, M. K. Structural requirements for the assembly of Norwalk virus-like particles J. Virol. 2002, 76 (8) 4044-55
73. Ball, J. M.; Estes, M. K.; Hardy, M. E.; Conner, M. E.; Opekun, A. R.; Graham, D. Y. Recombinant Norwalk virus-like particles as an oral vaccine Arch. Virol. Suppl. 1996, 12, 243-9
74. Gluck, R.; Mischler, R.; Brantschen, S.; Just, M.; Althaus, B.; Cryz, S. J., Jr. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A J. Clin. Invest. 1992, 90 (6) 2491-5
75. Felnerova, D.; Viret, J. F.; Gļck, R.; Moser, C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs Curr. Opin. Biotechnol. 2004, 15 (6) 518-29
76. Mengiardi, B.; Berger, R.; Just, M.; Gluck, R. Virosomes as carriers for combined vaccines Vaccine 1995, 13 (14) 1306-15
77. Bungener, L.; Huckriede, A.; Wilschut, J.; Daemen, T. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs Biosci. Rep. 2002, 22 (2) 323-38
78. Moser, C. Virosomes. In Novel immunologic adjuvants; Rappuoli, R.; de Gregorio, E., Eds.; Future medicine: Novato, CA, 2009; pp 43-53.
79. Bovier, P. A. Epaxal: a virosomal vaccine to prevent hepatitis A infection Expert Rev. Vaccines 2008, 7 (8) 1141-50
80. Herzog, C.; Hartmann, K.; Kunzi, V.; Kursteiner, O.; Mischler, R.; Lazar, H.; Gluck, R. Eleven years of Inflexal V- A virosomal adjuvanted influenza vaccine Vaccine 2009, 27 (33) 4381-7
81. Wiedermann, U.; Wiltschke, C.; Jasinska, J.; Kundi, M.; Zurbriggen, R.; Garner-Spitzer, E.; Bartsch, R.; Steger, G.; Pehamberger, H.; Scheiner, O.; Zielinski, C. C. A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study Breast Cancer Res. Treat. 2010, 119 (3) 673-83
82. Cavanagh, D. R.; Remarque, E. J.; Sauerwein, R. W.; Hermsen, C. C.; Luty, A. J. Influenza virosomes: a flu jab for malaria? Trends Parasitol. 2008, 24 (9) 382-5
83. Thompson, F. M.; Porter, D. W.; Okitsu, S. L.; Westerfeld, N.; Vogel, D.; Todryk, S.; Poulton, I.; Correa, S.; Hutchings, C.; Berthoud, T.; Dunachie, S.; Andrews, L.; Williams, J. L.; Sinden, R.; Gilbert, S. C.; Pluschke, G.; Zurbriggen, R.; Hill, A. V. Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial PLoS One 2008, 3 (1) e1493
84. Payne, A. M. Oral immunization against poliomyelitis Bull. W. H. O. 1960, 23 (6) 695-703
85. Woodward, W. E.; Gilman, R. H.; Hornick, R. B.; Libonati, J. P.; Cash, R. A. Efficacy of a live oral cholera vaccine in human volunteers Dev. Biol. Stand. 1976, 33, 108-12
86. Collins, F. M.; Carter, P. B. Comparative immunogenicity of heat-killed and living oral Salmonella vaccines Infect. Immun. 1972, 6 (4) 451-8
87. Mayer, L. Mucosal immunity and gastrointestinal antigen processing J. Pediatr. Gastroenterol. Nutr. 2000, 30 (Suppl) S4-12
88. Ball, J. M.; Graham, D. Y.; Opekun, A. R.; Gilger, M. A.; Guerrero, R. A.; Estes, M. K. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study Gastroenterology 1999, 117 (1) 40-8
89. Mora, J. R.; Bono, M. R.; Manjunath, N.; Weninger, W.; Cavanagh, L. L.; Rosemblatt, M.; Von Andrian, U. H. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells Nature 2003, 424 (6944) 88-93
90. Streeter, P. R.; Berg, E. L.; Rouse, B. T.; Bargatze, R. F.; Butcher, E. C. A tissue-specific endothelial cell molecule involved in lymphocyte homing Nature 1988, 331 (6151) 41-6
91. Mason, H. S.; Ball, J. M.; Shi, J. J.; Jiang, X.; Estes, M. K.; Arntzen, C. J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (11) 5335-40
92. Li, T.; Takeda, N.; Miyamura, T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice Vaccine 2001, 19 (25-26) 3476-84
93. Niikura, M.; Takamura, S.; Kim, G.; Kawai, S.; Saijo, M.; Morikawa, S.; Kurane, I.; Li, T. C.; Takeda, N.; Yasutomi, Y. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes Virology 2002, 293 (2) 273-80
94. Cortes-Perez, N. G.; Sapin, C.; Jaffrelo, L.; Daou, S.; Grill, J. P.; Langella, P.; Seksik, P.; Beaugerie, L.; Chwetzoff, S.; Trugnan, G. Rotavirus-like particles: a novel nanocarrier for the gut J. Biomed. Biotechnol. 2010, 2010, 1-10
95. Ghosh, S.; Kobayashi, N.; Nagashima, S.; Chawla-Sarkar, M.; Krishnan, T.; Ganesh, B.; Naik, T. N. Molecular characterization of the VP1, VP2, VP4, VP6, NSP1 and NSP2 genes of bovine group B rotaviruses: identification of a novel VP4 genotype Arch. Virol. 2010, 155 (2) 159-67
96. Morelli, A. B.; Becher, D.; Koernig, S.; Silva, A.; Drane, D.; Maraskovsky, E. ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases J. Med. Microbiol. 2012, 61 (Pt 7) 935-43
97. Midthun, K.; Kapikian, A. Z. Rotavirus vaccines: an overview Clin. Microbiol. Rev. 1996, 9 (3) 423-34
98. Buonaguro, L.; Visciano, M. L.; Tornesello, M. L.; Tagliamonte, M.; Biryahwaho, B.; Buonaguro, F. M. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation J. Virol. 2005, 79 (11) 7059-67
99. O'Neal, C. M.; Crawford, S. E.; Estes, M. K.; Conner, M. E. Rotavirus virus-like particles administered mucosally induce protective immunity J. Virol. 1997, 71 (11) 8707-17
100. Bertolotti-Ciarlet, A.; Ciarlet, M.; Crawford, S. E.; Conner, M. E.; Estes, M. K. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice Vaccine 2003, 21 (25-26) 3885-900
101. Azevedo, M. S.; Gonzalez, A. M.; Yuan, L.; Jeong, K. I.; Iosef, C.; Van Nguyen, T.; Lovgren-Bengtsson, K.; Morein, B.; Saif, L. J. An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model Clin. Vaccine Immunol. 2010, 17 (3) 420-8
102. Yuan, L.; Wen, K.; Azevedo, M. S.; Gonzalez, A. M.; Zhang, W.; Saif, L. J. Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs Vaccine 2008, 26 (26) 3322-31
103. Nardelli-Haefliger, D.; Roden, R. B.; Benyacoub, J.; Sahli, R.; Kraehenbuhl, J. P.; Schiller, J. T.; Lachat, P.; Potts, A.; De Grandi, P. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice Infect. Immun. 1997, 65 (8) 3328-36
104. Gerber, S.; Lane, C.; Brown, D. M.; Lord, E.; DiLorenzo, M.; Clements, J. D.; Rybicki, E.; Williamson, A. L.; Rose, R. C. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA J. Virol. 2001, 75 (10) 4752-60
105. Iwasaki, A. Mucosal dendritic cells Annu. Rev. Immunol. 2007, 25, 381-418
106. Kiyono, H.; Fukuyama, S. NALT- versus Peyer's-patch-mediated mucosal immunity Nat. Rev. Immunol. 2004, 4 (9) 699-710
107. Charpilienne, A.; Nejmeddine, M.; Berois, M.; Parez, N.; Neumann, E.; Hewat, E.; Trugnan, G.; Cohen, J. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells J. Biol. Chem. 2001, 276 (31) 29361-7
108. Kuper, C. F.; Koornstra, P. J.; Hameleers, D. M.; Biewenga, J.; Spit, B. J.; Duijvestijn, A. M.; van Breda Vriesman, P. J.; Sminia, T. The role of nasopharyngeal lymphoid tissue Immunol. Today 1992, 13 (6) 219-24
109. Atmar, R. L.; Bernstein, D. I.; Harro, C. D.; Al-Ibrahim, M. S.; Chen, W. H.; Ferreira, J.; Estes, M. K.; Graham, D. Y.; Opekun, A. R.; Richardson, C.; Mendelman, P. M. Norovirus vaccine against experimental human Norwalk Virus illness N. Engl. J. Med. 2011, 365 (23) 2178-87
110. Velasquez, L. S.; Shira, S.; Berta, A. N.; Kilbourne, J.; Medi, B. M.; Tizard, I.; Ni, Y.; Arntzen, C. J.; Herbst-Kralovetz, M. M. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine Vaccine 2011, 29 (32) 5221-31
111. Nardelli-Haefliger, D.; Lurati, F.; Wirthner, D.; Spertini, F.; Schiller, J. T.; Lowy, D. R.; Ponci, F.; De Grandi, P. Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine Vaccine 2005, 23 (28) 3634-41
112. Balmelli, C.; Demotz, S.; Acha-Orbea, H.; De Grandi, P.; Nardelli-Haefliger, D. Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles J. Virol. 2002, 76 (24) 12596-602
113. Liu, X. S.; Abdul-Jabbar, I.; Qi, Y. M.; Frazer, I. H.; Zhou, J. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice Virology 1998, 252 (1) 39-45
114. Benyacoub, J.; Hopkins, S.; Potts, A.; Kelly, S.; Kraehenbuhl, J. P.; Curtiss, R., 3rd; De Grandi, P.; Nardelli-Haefliger, D. The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice Infect. Immun. 1999, 67 (7) 3674-9
115. Nardelli-Haefliger, D.; Roden, R.; Balmelli, C.; Potts, A.; Schiller, J.; De Grandi, P. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice J. Virol. 1999, 73 (11) 9609-13
116. Yao, Q.; Vuong, V.; Li, M.; Compans, R. W. Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity Vaccine 2002, 20 (19-20) 2537-45
117. Coste, A.; Sirard, J. C.; Johansen, K.; Cohen, J.; Kraehenbuhl, J. P. Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea J. Virol. 2000, 74 (19) 8966-71
118. Blutt, S. E.; Warfield, K. L.; O'Neal, C. M.; Estes, M. K.; Conner, M. E. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs) Vaccine 2006, 24 (8) 1170-9
119. Buonaguro, L.; Devito, C.; Tornesello, M. L.; Schroder, U.; Wahren, B.; Hinkula, J.; Buonaguro, F. M. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity Vaccine 2007, 25 (32) 5968-77
120. Buonaguro, L.; Tagliamonte, M.; Visciano, M. L.; Andersen, H.; Lewis, M.; Pal, R.; Tornesello, M. L.; Schroeder, U.; Hinkula, J.; Wahren, B.; Buonaguro, F. M. Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration Clin. Vaccine Immunol. 2012, 19 (6) 970-3
121. Longet, S.; Schiller, J. T.; Bobst, M.; Jichlinski, P.; Nardelli-Haefliger, D. A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection J. Virol. 2011, 85 (24) 13253-9
122. Revaz, V.; Zurbriggen, R.; Moser, C.; Schiller, J. T.; Ponci, F.; Bobst, M.; Nardelli-Haefliger, D. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants Antiviral Res. 2007, 76 (1) 75-85
123. Perrone, L. A.; Ahmad, A.; Veguilla, V.; Lu, X.; Smith, G.; Katz, J. M.; Pushko, P.; Tumpey, T. M. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge J. Virol. 2009, 83 (11) 5726-34
124. Johansson, E. L.; Wassen, L.; Holmgren, J.; Jertborn, M.; Rudin, A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans Infect. Immun. 2001, 69 (12) 7481-6
125. Liu, X. S.; Liu, W. J.; Zhao, K. N.; Liu, Y. H.; Leggatt, G.; Frazer, I. H. Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses Immunol. Cell Biol. 2002, 80 (1) 21-9
126. Wassen, L.; Schon, K.; Holmgren, J.; Jertborn, M.; Lycke, N. Local intravaginal vaccination of the female genital tract Scand. J. Immunol. 1996, 44 (4) 408-14
127. Del Giudice, G.; Podda, A.; Rappuoli, R. What are the limits of adjuvanticity? Vaccine 2001, 20 (Suppl 1) S38-41
128. Dayal, M. B.; Wheeler, J.; Williams, C. J.; Barnhart, K. T. Disruption of the upper female reproductive tract epithelium by nonoxynol-9 Contraception 2003, 68 (4) 273-9
129. Mesquita, P. M.; Cheshenko, N.; Wilson, S. S.; Mhatre, M.; Guzman, E.; Fakioglu, E.; Keller, M. J.; Herold, B. C. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety J. Infect. Dis. 2009, 200 (4) 599-608
130. Hunter, Z.; Tumban, E.; Dziduszko, A.; Chackerian, B. Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses Vaccine 2011, 29 (28) 4584-92
131. Pudney, J.; Quayle, A. J.; Anderson, D. J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone Biol. Reprod. 2005, 73 (6) 1253-63
132. Ivanov, S.; Khadzhiolov, N. Human papilloma virus (HPV) infection and its relationship with central intra-epithelial neoplasia (CIN) Akush Ginekol. 2002, 41 (2) 34-5
133. Yeaman, G. R.; Guyre, P. M.; Fanger, M. W.; Collins, J. E.; White, H. D.; Rathbun, W.; Orndorff, K. A.; Gonzalez, J.; Stern, J. E.; Wira, C. R. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium J. Leukocyte Biol 1997, 61 (4) 427-35
134. Kozlowski, P. A.; Williams, S. B.; Lynch, R. M.; Flanigan, T. P.; Patterson, R. R.; Cu-Uvin, S.; Neutra, M. R. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle J. Immunol. 2002, 169 (1) 566-74
135. Gordon, S. N.; Kines, R. C.; Kutsyna, G.; Ma, Z. M.; Hryniewicz, A.; Roberts, J. N.; Fenizia, C.; Hidajat, R.; Brocca-Cofano, E.; Cuburu, N.; Buck, C. B.; Bernardo, M. L.; Robert-Guroff, M.; Miller, C. J.; Graham, B. S.; Lowy, D. R.; Schiller, J. T.; Franchini, G. Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA J. Immunol. 2012, 188 (2) 714-23
136. Sedgmen, B. J.; Meeusen, E. N.; Lofthouse, S. A. Alternative routes of mucosal immunization in large animals Immunol. Cell Biol. 2004, 82 (1) 10-6
137. Owen, R. L.; Piazza, A. J.; Ermak, T. H. Ultrastructural and cytoarchitectural features of lymphoreticular organs in the colon and rectum of adult BALB/c mice Am. J. Anat. 1991, 190 (1) 10-8
138. Lehner, T.; Bergmeier, L. A.; Panagiotidi, C.; Tao, L.; Brookes, R.; Klavinskis, L. S.; Walker, P.; Walker, J.; Ward, R. G.; Hussain, L. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein Science 1992, 258 (5086) 1365-9
139. Parez, N.; Fourgeux, C.; Mohamed, A.; Dubuquoy, C.; Pillot, M.; Dehee, A.; Charpilienne, A.; Poncet, D.; Schwartz-Cornil, I.; Garbarg-Chenon, A. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection J. Virol. 2006, 80 (4) 1752-61
140. Pedersen, G. K.; Ebensen, T.; Gjeraker, I. H.; Svindland, S.; Bredholt, G.; Guzman, C. A.; Cox, R. J. Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP PLoS One 2011, 6 (11) e26973
141. Cusi, M. G.; Lomagistro, M. M.; Valassina, M.; Valensin, P. E.; Gluck, R. Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosomal vaccine Vaccine 2000, 18 (25) 2838-42
142. Durrer, P.; Gluck, U.; Spyr, C.; Lang, A. B.; Zurbriggen, R.; Herzog, C.; Gluck, R. Mucosal antibody response induced with a nasal virosome-based influenza vaccine Vaccine 2003, 21 (27-30) 4328-34
143. Gluck, R. Intranasal immunization against influenza J. Aerosol. Med. 2002, 15 (2) 221-8
144. Cusi, M. G.; Zurbriggen, R.; Correale, P.; Valassina, M.; Terrosi, C.; Pergola, L.; Valensin, P. E.; Gluck, R. Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity Vaccine 2002, 20 (29-30) 3436-42
145. Bomsel, M.; Tudor, D.; Drillet, A. S.; Alfsen, A.; Ganor, Y.; Roger, M. G.; Mouz, N.; Amacker, M.; Chalifour, A.; Diomede, L.; Devillier, G.; Cong, Z.; Wei, Q.; Gao, H.; Qin, C.; Yang, G. B.; Zurbriggen, R.; Lopalco, L.; Fleury, S. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges Immunity 2011, 34 (2) 269-80
146. Singh, R.; Verma, P. C.; Singh, S. Immunogenicity and protective efficacy of virosome based vaccines against Newcastle disease Trop. Anim. Health Prod. 2010, 42 (3) 465-71
147. Vacher, G.; Gremion, C.; Moser, C.; Stoffel, S. A.; Amacker, M.; Zurbriggen, R.; Gurny, R.; Borchard, G. Virosomal C.albicans vaccine for vaginal
148. De Bernardis, F.; Amacker, M.; Arancia, S.; Sandini, S.; Gremion, C.; Zurbriggen, R.; Moser, C.; Cassone, A. A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models Vaccine 2012, 30 (30) 4490-8
149. Ngoc, P. L.; Gold, D. R.; Tzianabos, A. O.; Weiss, S. T.; Celedon, J. C. Cytokines, allergy, and asthma Curr. Opin. Allergy Clin. Immunol. 2005, 5 (2) 161-6
150. Huber, V. C.; McKeon, R. M.; Brackin, M. N.; Miller, L. A.; Keating, R.; Brown, S. A.; Makarova, N.; Perez, D. R.; Macdonald, G. H.; McCullers, J. A. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza Clin. Vaccine Immunol. 2006, 13 (9) 981-90
151. Stegmann, T.; Kamphuis, T.; Meijerhof, T.; Goud, E.; de Haan, A.; Wilschut, J. Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation Vaccine 2010, 28 (34) 5543-50
152. Buckland, B. C. The process development challenge for a new vaccine Nat. Med. 2005, 11 (4 Suppl) S16-9
153. Buonaguro, L.; Tornesello, M. L.; Buonaguro, F. M. Virus-like particles as particulate vaccines Curr. HIV Res. 2010, 8 (4) 299-309
154. Tacket, C. O.; Sztein, M. B.; Losonsky, G. A.; Wasserman, S. S.; Estes, M. K. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers Clin. Immunol. 2003, 108 (3) 241-7
155. Tacket, C. O.; Mason, H. S.; Losonsky, G.; Estes, M. K.; Levine, M. M.; Arntzen, C. J. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes J. Infect. Dis. 2000, 182 (1) 302-5